Long-Term Home Oxygen Therapy in Children: Evidences and Open Issues

Detalhes bibliográficos
Autor(a) principal: Oliveira, Lia
Data de Publicação: 2014
Outros Autores: Coelho, Joana, Ferreira, Rosário, Nunes, Teresa, Saianda, Ana, Pereira, Luisa, Bandeira, Teresa
Tipo de documento: Artigo
Idioma: por
eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5185
Resumo: Introduction: Long-term home oxygen therapy is indicated for patients with chronic hypoxemia. We intend to describe pediatric population on long-term home oxygen therapy followed-up at Pediatric Respiratory Unit of a tertiary care hospital between 2003-2012 and to compare with previous 1991-2000 review; to verify conformity with international and national recommendations and need for specific pediatric national guidelines, non-existent in Portugal.Material and Methods: Retrospective, descriptive and comparative study based on clinical files review. Review the guidelines for oxygen therapy in pediatric population.Results: We studied 86 patients (59.3% males). The median age at the beginning of oxygen therapy was 0.0 (0.0-216.0) months, with a median duration of 15.0 (3.0-223.0) months. The most frequent diagnosis was bronchopulmonary dysplasia (53.5%), followed by bronchiolitis obliterans (14.0%), neurologic disorders (10.5%), cystic fibrosis (8.1%), miscellaneous syndromes (5.8%), sickle-cell disease (3.5%), other neonatal lung diseases (2.3%) and interstitial lung diseases (2.3%). Are maintained on follow-up 53 (61.6%) patients, 38 on oxygen therapy; 12 (13.9%) died. The median time of follow-up was 39.5 (1.0-246.0) months, minim on other neonatal lung diseases and maximum on cystic fibrosis. Comparing with previous review, this shows a relative increase in bronchiolitis obliterans and bronchopulmonary dysplasia patients, with increased duration in the latter, and inclusion of neurologic and hematologic patients.Discussion: Prescription of long-term oxygen therapy in pediatric age mainly occurs in specific diseases of infants and pre-school aged. Neurologic and hematologic patients represent new indications, similarly to international publications.Conclusion: The knowledge of national reality and pediatric orientations are needed for care plans and rational prescription.Keywords: Child; Long-Term Care; Respiratory Insufficiency; Oxygen Inhalation Therapy; Portugal.
id RCAP_b8d7f8f1800313bfa191c90e1cf010f6
oai_identifier_str oai:ojs.www.actamedicaportuguesa.com:article/5185
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Long-Term Home Oxygen Therapy in Children: Evidences and Open IssuesOxigenoterapia Domiciliária de Longa Duração na Criança: Evidências e Questões em AbertoIntroduction: Long-term home oxygen therapy is indicated for patients with chronic hypoxemia. We intend to describe pediatric population on long-term home oxygen therapy followed-up at Pediatric Respiratory Unit of a tertiary care hospital between 2003-2012 and to compare with previous 1991-2000 review; to verify conformity with international and national recommendations and need for specific pediatric national guidelines, non-existent in Portugal.Material and Methods: Retrospective, descriptive and comparative study based on clinical files review. Review the guidelines for oxygen therapy in pediatric population.Results: We studied 86 patients (59.3% males). The median age at the beginning of oxygen therapy was 0.0 (0.0-216.0) months, with a median duration of 15.0 (3.0-223.0) months. The most frequent diagnosis was bronchopulmonary dysplasia (53.5%), followed by bronchiolitis obliterans (14.0%), neurologic disorders (10.5%), cystic fibrosis (8.1%), miscellaneous syndromes (5.8%), sickle-cell disease (3.5%), other neonatal lung diseases (2.3%) and interstitial lung diseases (2.3%). Are maintained on follow-up 53 (61.6%) patients, 38 on oxygen therapy; 12 (13.9%) died. The median time of follow-up was 39.5 (1.0-246.0) months, minim on other neonatal lung diseases and maximum on cystic fibrosis. Comparing with previous review, this shows a relative increase in bronchiolitis obliterans and bronchopulmonary dysplasia patients, with increased duration in the latter, and inclusion of neurologic and hematologic patients.Discussion: Prescription of long-term oxygen therapy in pediatric age mainly occurs in specific diseases of infants and pre-school aged. Neurologic and hematologic patients represent new indications, similarly to international publications.Conclusion: The knowledge of national reality and pediatric orientations are needed for care plans and rational prescription.Keywords: Child; Long-Term Care; Respiratory Insufficiency; Oxygen Inhalation Therapy; Portugal.Introdução: Oxigenoterapia domiciliária de longa duração está indicada em doentes com hipoxémia crónica. Pretendemos descrever a população em programa de oxigenoterapia domiciliária de longa duração acompanhada numa Unidade de Pneumologia Pediátrica de Hospital Terciário entre 2003-2012 e comparar com revisão de 1991-2000; verificar conformidade com orientações nacionais e internacionais, refletindo sobre necessidade de orientações nacionais especificamente pediátricas, inexistentes em Portugal.Material e Métodos: Estudo retrospetivo, descritivo e comparativo por consulta de processo clínico. Pesquisa de orientações sobre oxigenoterapia em idade pediátrica.Resultados: Incluímos 86 doentes (59,3% rapazes). A idade mediana de início da oxigenoterapia foi 0,0 (0,0-216,0) meses e a duração mediana de 15,0 (3,0-223,0) meses. O diagnóstico mais frequente foi displasia broncopulmonar (53,5%), seguindo-se bronquiolite obliterante (14,0%), doença neurológica (10,5%), fibrose quística (8,1%), síndromes polimalformativas (5,8%), doença de células falciformes (3,5%), outras doenças pulmonares neonatais (2,3%) e doenças pulmonares intersticiais (2,3%). Mantêm acompanhamento 53 (61,6%) doentes, 38 mantendo oxigenoterapia; 12 (13,9%) faleceram. O tempo mediano de seguimento foi 39,5 (1,0-246,0) meses, mínimo nas outras doenças pulmonares neonatais e máximo na fibrose quística. Comparativamente ao estudo anterior revela aumento relativo dos lactentes com bronquiolite obliterante e displasia broncopulmonar, aumento da duração nestes últimos e inclusãode doentes neurológicos e hematológicos.Discussão: A prescrição de oxigenoterapia domiciliária de longa duração em pediatria ocorre sobretudo em doenças específicas dos lactentes e idade pré-escolar. Doentes neurológicos e hematológicos são novos grupos de prescrição, à semelhança da literatura internacional.Conclusão: O conhecimento da realidade nacional e orientações pediátricas são relevantes para organização de cuidados eprescrição racional.Palavras-chave: Criança; Cuidados de Longa Duração;Insuficiência Respiratória; Oxigenoterapia.Ordem dos Médicos2014-12-30info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfapplication/pdfapplication/octet-streamhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5185oai:ojs.www.actamedicaportuguesa.com:article/5185Acta Médica Portuguesa; Vol. 27 No. 6 (2014): November-December; 717-725Acta Médica Portuguesa; Vol. 27 N.º 6 (2014): Novembro-Dezembro; 717-7251646-07580870-399Xreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporenghttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5185https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5185/4145https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5185/4247https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5185/7313Oliveira, LiaCoelho, JoanaFerreira, RosárioNunes, TeresaSaianda, AnaPereira, LuisaBandeira, Teresainfo:eu-repo/semantics/openAccess2022-12-20T11:04:14Zoai:ojs.www.actamedicaportuguesa.com:article/5185Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:19:02.618473Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Long-Term Home Oxygen Therapy in Children: Evidences and Open Issues
Oxigenoterapia Domiciliária de Longa Duração na Criança: Evidências e Questões em Aberto
title Long-Term Home Oxygen Therapy in Children: Evidences and Open Issues
spellingShingle Long-Term Home Oxygen Therapy in Children: Evidences and Open Issues
Oliveira, Lia
title_short Long-Term Home Oxygen Therapy in Children: Evidences and Open Issues
title_full Long-Term Home Oxygen Therapy in Children: Evidences and Open Issues
title_fullStr Long-Term Home Oxygen Therapy in Children: Evidences and Open Issues
title_full_unstemmed Long-Term Home Oxygen Therapy in Children: Evidences and Open Issues
title_sort Long-Term Home Oxygen Therapy in Children: Evidences and Open Issues
author Oliveira, Lia
author_facet Oliveira, Lia
Coelho, Joana
Ferreira, Rosário
Nunes, Teresa
Saianda, Ana
Pereira, Luisa
Bandeira, Teresa
author_role author
author2 Coelho, Joana
Ferreira, Rosário
Nunes, Teresa
Saianda, Ana
Pereira, Luisa
Bandeira, Teresa
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Oliveira, Lia
Coelho, Joana
Ferreira, Rosário
Nunes, Teresa
Saianda, Ana
Pereira, Luisa
Bandeira, Teresa
description Introduction: Long-term home oxygen therapy is indicated for patients with chronic hypoxemia. We intend to describe pediatric population on long-term home oxygen therapy followed-up at Pediatric Respiratory Unit of a tertiary care hospital between 2003-2012 and to compare with previous 1991-2000 review; to verify conformity with international and national recommendations and need for specific pediatric national guidelines, non-existent in Portugal.Material and Methods: Retrospective, descriptive and comparative study based on clinical files review. Review the guidelines for oxygen therapy in pediatric population.Results: We studied 86 patients (59.3% males). The median age at the beginning of oxygen therapy was 0.0 (0.0-216.0) months, with a median duration of 15.0 (3.0-223.0) months. The most frequent diagnosis was bronchopulmonary dysplasia (53.5%), followed by bronchiolitis obliterans (14.0%), neurologic disorders (10.5%), cystic fibrosis (8.1%), miscellaneous syndromes (5.8%), sickle-cell disease (3.5%), other neonatal lung diseases (2.3%) and interstitial lung diseases (2.3%). Are maintained on follow-up 53 (61.6%) patients, 38 on oxygen therapy; 12 (13.9%) died. The median time of follow-up was 39.5 (1.0-246.0) months, minim on other neonatal lung diseases and maximum on cystic fibrosis. Comparing with previous review, this shows a relative increase in bronchiolitis obliterans and bronchopulmonary dysplasia patients, with increased duration in the latter, and inclusion of neurologic and hematologic patients.Discussion: Prescription of long-term oxygen therapy in pediatric age mainly occurs in specific diseases of infants and pre-school aged. Neurologic and hematologic patients represent new indications, similarly to international publications.Conclusion: The knowledge of national reality and pediatric orientations are needed for care plans and rational prescription.Keywords: Child; Long-Term Care; Respiratory Insufficiency; Oxygen Inhalation Therapy; Portugal.
publishDate 2014
dc.date.none.fl_str_mv 2014-12-30
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5185
oai:ojs.www.actamedicaportuguesa.com:article/5185
url https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5185
identifier_str_mv oai:ojs.www.actamedicaportuguesa.com:article/5185
dc.language.iso.fl_str_mv por
eng
language por
eng
dc.relation.none.fl_str_mv https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5185
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5185/4145
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5185/4247
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5185/7313
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
application/octet-stream
dc.publisher.none.fl_str_mv Ordem dos Médicos
publisher.none.fl_str_mv Ordem dos Médicos
dc.source.none.fl_str_mv Acta Médica Portuguesa; Vol. 27 No. 6 (2014): November-December; 717-725
Acta Médica Portuguesa; Vol. 27 N.º 6 (2014): Novembro-Dezembro; 717-725
1646-0758
0870-399X
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799130641469538304